Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
251.35B | 252.50B | 238.72B | 213.79B | 198.04B | 217.53B | Gross Profit |
62.40B | 57.83B | 49.38B | 47.82B | 42.28B | 50.28B | EBIT |
23.81B | 18.01B | 13.85B | 15.46B | 10.23B | 18.71B | EBITDA |
32.01B | 27.32B | 25.47B | 26.37B | 19.48B | 20.43B | Net Income Common Stockholders |
17.69B | 14.28B | 11.97B | 13.95B | 6.89B | 9.31B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
72.59B | 97.61B | 87.29B | 106.24B | 89.44B | 75.53B | Total Assets |
375.02B | 366.77B | 348.36B | 339.73B | 316.25B | 297.17B | Total Debt |
42.06B | 43.63B | 43.42B | 58.44B | 58.04B | 52.06B | Net Debt |
-30.53B | -53.98B | -43.87B | -47.80B | -31.40B | -23.46B | Total Liabilities |
187.50B | 188.16B | 187.72B | 188.65B | 174.26B | 164.68B | Stockholders Equity |
185.72B | 176.98B | 159.10B | 149.44B | 140.40B | 130.80B |
Cash Flow | Free Cash Flow | ||||
0.00 | 11.46B | -7.09B | 13.52B | 6.44B | 6.13B | Operating Cash Flow |
0.00 | 21.71B | -986.00M | 22.32B | 14.71B | 18.96B | Investing Cash Flow |
0.00 | -6.84B | 947.00M | -2.98B | -3.24B | -13.17B | Financing Cash Flow |
0.00 | -4.90B | -20.11B | -2.86B | 2.77B | -6.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
€3.28B | 29.64 | 9.67% | 1.20% | ― | ― | ||
66 Neutral | $4.50B | 12.28 | 5.32% | 248.52% | 4.13% | -12.36% | |
$3.21B | 15.72 | 6.10% | 4.04% | ― | ― | ||
$3.46B | 11.21 | 7.66% | 2.91% | ― | ― | ||
$2.54B | 1,020.98 | 0.06% | 3.88% | ― | ― | ||
$3.38B | 59.27 | 2.48% | 3.46% | ― | ― | ||
67 Neutral | ¥425.12B | 30.11 | 2.94% | 5.17% | -18.62% |